7th Annual Cell & Gene Therapy Manufacturing Congress28 - 29 October 2021 | London, UK
With knowledge-sharing & innovation in the manufacturing, regulation and commercialisation of advanced therapies more critical than ever, hear from cell & gene therapy leaders targeting increasingly difficult disease areas.
The Cell & Gene Therapy Manufacturing Congress includes...
Over 250 attendees from global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions pioneering cell & gene therapy manufacturing.
Over 20 presentations and case studies providing actionable insights to improve your manufacturing workflow and enable scale-up, automation and high quality.
PLUS Interactive opportunities including:
- Panel Discussion: Cost-Effective Cell & Gene Therapy Manufacture
- Panel Discussion: Disruptive Technologies in Gene Therapy Manufacturing
- Workshop: Strategies for Commercialisation of CGT Therapies
This Year's Agenda at a Glance
Strategies for CGT Manufacturing & Commercialisation
- Autologous vs. allogeneic products for cost-efficient, scalable manufacturing of cell & gene therapy products
- Viral and non-viral vector engineering
- Analytics & quality control
CGT Bioprocess Technologies: Automation, Digitalisation & Manufacturing
- Scale-up of cell & gene therapy manufacturing through automation and digitalisation
- Continuous manufacturing considerations
Stem Cell Manufacturing
- Derivation, manipulation, characterisation and bioprocessing of iPSCs
- Strategies to optimise stem cell bioprocessing
